Pharmaceutical Business review

US Oncology’s CFO to resign

After Mr McCook’s resignation, Vicki Hitzhusen, chief accounting officer of the company will serve as interim principal financial officer. The company intends to initiate a search for a new CFO.

Bruce Broussard, CEO of US Oncology, said: “During his tenure at US Oncology, Rick played a key role in overseeing our financial operations infrastructure and consummating equity and debt financings for the company.”